LIPG
Endothelial lipase
Also known as: EDL, LIPG_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y5X9
- Gene
- LIPG
- Ensembl
- ENSG00000101670
- Chromosome
- 18
- Canonical length
- 500 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene has substantial phospholipase activity and may be involved in lipoprotein metabolism and vascular biology. This protein is designated a member of the TG lipase family by its sequence and characteristic lid region which provides substrate specificity for enzymes of the TG lipase family. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
500 residues, UniProt reviewed canonical sequence.
>Q9Y5X9|LIPG
1 MSNSVPLLCF WSLCYCFAAG SPVPFGPEGR LEDKLHKPKA TQTEVKPSVR FNLRTSKDPE
61 HEGCYLSVGH SQPLEDCSFN MTAKTFFIIH GWTMSGIFEN WLHKLVSALH TREKDANVVV
121 VDWLPLAHQL YTDAVNNTRV VGHSIARMLD WLQEKDDFSL GNVHLIGYSL GAHVAGYAGN
181 FVKGTVGRIT GLDPAGPMFE GADIHKRLSP DDADFVDVLH TYTRSFGLSI GIQMPVGHID
241 IYPNGGDFQP GCGLNDVLGS IAYGTITEVV KCEHERAVHL FVDSLVNQDK PSFAFQCTDS
301 NRFKKGICLS CRKNRCNSIG YNAKKMRNKR NSKMYLKTRA GMPFRVYHYQ MKIHVFSYKN
361 MGEIEPTFYV TLYGTNADSQ TLPLEIVERI EQNATNTFLV YTEEDLGDLL KIQLTWEGAS
421 QSWYNLWKEF RSYLSQPRNP GRELNIRRIR VKSGETQRKL TFCTEDPENT SISPGRELWF
481 RKCRDGWRMK NETSPTVELPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LIPG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 227 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 227 nTPM
- placenta: 140 nTPM
- liver: 33 nTPM
- seminal vesicle: 20 nTPM
- appendix: 15 nTPM
- urinary bladder: 13 nTPM
Single-cell type
- cone photoreceptor cells: 162 nCPM
- tuft cells: 161 nCPM
- extravillous trophoblasts: 145 nCPM
- hepatocytes: 120 nCPM
- endometrial luminal cells: 119 nCPM
- retinal pigment epithelial cells: 98 nCPM
Immune cell
- basophil: 0.2 nTPM
- neutrophil: 0.2 nTPM
- memory B-cell: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebellum: 11 nTPM
- thalamus: 11 nTPM
- hippocampal formation: 9 nTPM
- medulla oblongata: 8.8 nTPM
- midbrain: 8.6 nTPM
- cerebral cortex: 8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.18
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.86
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cholesterol homeostasis
- fatty acid biosynthetic process
- high-density lipoprotein particle remodeling
- lipid metabolic process
- phospholipid catabolic process
- phospholipid homeostasis
- positive regulation of cholesterol transport
- positive regulation of high-density lipoprotein particle clearance
- regulation of lipoprotein metabolic process
- response to nutrient
- reverse cholesterol transport
- triglyceride catabolic process
Molecular functions
- heparin binding
- lipoprotein lipase activity
- phospholipase A1 activity
- phospholipase activity
- triacylglycerol lipase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LIPG as an antibody target. Whether an autoantibody or antibody against LIPG could matter depends on whether native LIPG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LIPG is annotated as secreted, so native LIPG circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label LIPG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...